Position in IMTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,500,737
New position
Shares Held
254,140
first reported quarter
Ownership
0.186%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Atom Investors LP holds $125,877,416 across 43 Biotechnology names. IMTX ranks #20 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
319,316 | $16,687,454 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
107,753 | $9,042,631 | |
| 3 | CELC |
Celcuity Inc.
|
76,321 | $8,711,278 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
190,773 | $7,272,266 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
21,196 | $6,829,139 | |
| 6 | IMNM |
Immunome Inc.
|
306,880 | $6,711,465 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
158,509 | $6,295,977 | |
| 8 | ERAS |
Erasca, Inc.
|
345,587 | $5,591,597 |
All Filings in IMTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,500,737 | 254,140 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||